Neuroinflammation in bipolar disorder – A [11C]-(R)-PK11195 positron emission tomography study

[1]  S. Maier,et al.  Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis , 2014, Molecular Psychiatry.

[2]  M. Cambron,et al.  Astrocyte loss and astrogliosis in neuroinflammatory disorders , 2014, Neuroscience Letters.

[3]  J. Rinne,et al.  Detection of Microglial Activation in an Acute Model of Neuroinflammation Using PET and Radiotracers 11C-(R)-PK11195 and 18F-GE-180 , 2014, The Journal of Nuclear Medicine.

[4]  Huibert Burger,et al.  Relationship between clinical features and inflammation‐related monocyte gene expression in bipolar disorder – towards a better understanding of psychoimmunological interactions , 2014, Bipolar disorders.

[5]  D. Brooks,et al.  Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART , 2014, AIDS.

[6]  R. Carson,et al.  The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: A [11C]PBR28 PET study , 2013, Brain, Behavior, and Immunity.

[7]  Eduard Vieta,et al.  A systematic literature review of resting state network--functional MRI in bipolar disorder. , 2013, Journal of affective disorders.

[8]  J. Homberg,et al.  Altered inflammatory responsiveness in serotonin transporter mutant rats , 2013, Journal of Neuroinflammation.

[9]  Teresa A. Victor,et al.  Inflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities , 2013, Brain, Behavior, and Immunity.

[10]  Kimberly J. Jenko,et al.  A Genetic Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of Neuroinflammation , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  L. Pont-Lezica,et al.  The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes , 2012, Journal of leukocyte biology.

[12]  Philippe Hantraye,et al.  Reactive Astrocytes Overexpress TSPO and Are Detected by TSPO Positron Emission Tomography Imaging , 2012, The Journal of Neuroscience.

[13]  J. Peiris,et al.  Editorial: Macrophage heterogeneity and responses to influenza virus infection , 2012, Journal of leukocyte biology.

[14]  Ben A. Barres,et al.  Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner , 2012, Neuron.

[15]  D. Brooks,et al.  Cerebral microglial activation in patients with hepatitis c: in vivo evidence of neuroinflammation , 2012, Journal of viral hepatitis.

[16]  J. Korf,et al.  The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depression. , 2012, Journal of Alzheimer's disease : JAD.

[17]  M. Giustetto,et al.  Synaptic Pruning by Microglia Is Necessary for Normal Brain Development , 2011, Science.

[18]  M. Lynch,et al.  Long Term Potentiation Is Impaired in Membrane Glycoprotein CD200-deficient Mice , 2011, The Journal of Biological Chemistry.

[19]  Ronald Boellaard,et al.  Widespread and Prolonged Increase in (R)-11C-PK11195 Binding After Traumatic Brain Injury , 2011, The Journal of Nuclear Medicine.

[20]  Eleonora Aronica,et al.  Inflammation in epilepsy: Clinical observations , 2011, Epilepsia.

[21]  T. Guilarte,et al.  Translocator protein (18 kDa)/peripheral benzodiazepine receptor specific ligands induce microglia functions consistent with an activated state , 2011, Glia.

[22]  S. Wisniewski,et al.  Positron emission tomography imaging of peripheral benzodiazepine receptor binding in human immunodeficiency virus-infected subjects with and without cognitive impairment , 2006, Journal of NeuroVirology.

[23]  G. Enikolopov,et al.  Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. , 2010, Cell stem cell.

[24]  Jun-Feng Wang,et al.  Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness. , 2010, Journal of psychiatry & neuroscience : JPN.

[25]  Thomas G Schulze,et al.  Genetic research into bipolar disorder: the need for a research framework that integrates sophisticated molecular biology and clinically informed phenotype characterization. , 2010, The Psychiatric clinics of North America.

[26]  T. Suppes,et al.  Gender and depressive symptoms in 711 patients with bipolar disorder evaluated prospectively in the Stanley Foundation bipolar treatment outcome network. , 2010, The American journal of psychiatry.

[27]  J Nucl Med , 2010 .

[28]  Rudi A. Dierckx,et al.  Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study , 2009, Journal of Nuclear Medicine.

[29]  E. Brown.  Effects of Glucocorticoids on Mood, Memory, and the Hippocampus , 2009, Annals of the New York Academy of Sciences.

[30]  K. Coburn,et al.  Cerebral blood flow, metabolic, receptor, and transporter changes in bipolar disorder: The role of PET and SPECT studies , 2009, International review of psychiatry.

[31]  R. Boellaard,et al.  Microglia Activation in Recent-Onset Schizophrenia: A Quantitative (R)-[11C]PK11195 Positron Emission Tomography Study , 2008, Biological Psychiatry.

[32]  R. Dierckx,et al.  PET imaging of the peripheral benzodiazepine receptor: monitoring disease progression and therapy response in neurodegenerative disorders. , 2008, Current pharmaceutical design.

[33]  E. Réal,et al.  Prenatal Activation of Microglia Induces Delayed Impairment of Glutamatergic Synaptic Function , 2008, PloS one.

[34]  W. Nolen,et al.  A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. , 2008, Archives of general psychiatry.

[35]  H. Steinbusch,et al.  Tryptophan breakdown pathway in bipolar mania. , 2007, Journal of affective disorders.

[36]  Jun-Feng Wang,et al.  Immunoreactivity of 43 kDa growth-associated protein is decreased in post mortem hippocampus of bipolar disorder and schizophrenia. , 2007, Neuroscience letters.

[37]  Z. Herman,et al.  Cytokines in schizophrenia and the effects of antipsychotic drugs , 2006, Brain, Behavior, and Immunity.

[38]  R. Burke,et al.  The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia , 2006, Molecular Psychiatry.

[39]  S. Rauch,et al.  Impaired Recruitment of the Dorsolateral Prefrontal Cortex and Hippocampus During Encoding in Bipolar Disorder , 2006, Biological Psychiatry.

[40]  B. Dell’Osso,et al.  Changes in peripheral benzodiazepine receptors in patients with bipolar disorder , 2005, Neuropsychiatric disease and treatment.

[41]  Olaf B. Paulson,et al.  MR-based automatic delineation of volumes of interest in human brain PET images using probability maps , 2005, NeuroImage.

[42]  E. Gundelfinger,et al.  Impaired Synaptic Function in the Microglial KARAP/DAP12-Deficient Mouse , 2004, The Journal of Neuroscience.

[43]  R. Feiwell,et al.  Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. , 2003, The American journal of psychiatry.

[44]  K. Fujikawa,et al.  Influence of peripheral inflammation on growth-associated phosphoprotein (GAP-43) expression in dorsal root ganglia and on nerve recovery after crush injury , 2003, Neuroscience Research.

[45]  R. Banati,et al.  Visualising microglial activation in vivo , 2002, Glia.

[46]  A J Rush,et al.  The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. , 2001, Journal of affective disorders.

[47]  A. Rush,et al.  The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology. , 2001, Journal of affective disorders.

[48]  T. Pollmächer,et al.  Effects of antipsychotic drugs on cytokine networks. , 2000, Journal of psychiatric research.

[49]  Rybakowski Jk.  Antiviral and immunomodulatory effect of lithium. , 2000 .

[50]  J. Rybakowski.  Antiviral and immunomodulatory effect of lithium. , 2000, Pharmacopsychiatry.

[51]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[52]  M. Maes,et al.  The monocyte-T-lymphocyte hypothesis of major depression , 1995, Psychoneuroendocrinology.

[53]  Y. Benjamini,et al.  More powerful procedures for multiple significance testing. , 1990, Statistics in medicine.

[54]  R. Ader,et al.  Brain, behavior, and immunity , 1987, Brain, Behavior, and Immunity.

[55]  R. C. Young,et al.  A Rating Scale for Mania: Reliability, Validity and Sensitivity , 1978, British Journal of Psychiatry.